$EMED
Electromedical Technologies, Inc
CIK:0001715819|SEC Filings
Statement of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Net sales | $ 42,526 | $ 323,613 | $ 570,415 | $ 997,213 |
| Cost of sales | 11,881 | 72,437 | 149,128 | 222,652 |
| Gross profit | 30,645 | 251,176 | 421,287 | 774,561 |
| Selling, general and administrative expenses | 411,683 | 490,205 | 1,209,046 | 2,616,531 |
| Loss from operations | (381,038) | (239,029) | (787,759) | (1,841,970) |
| Other income (expense) | ||||
| Interest expense | (54,914) | (162,121) | (172,535) | (834,809) |
| Gain on sale of fixed asset | 0 | 0 | 0 | 1,193,676 |
| Change in fair value of derivative liabilities | (338,698) | 63,069 | (677,633) | (63,889) |
| Gain (loss) on derivative liabilities | 46,486 | 11,361 | (28,705) | (355,597) |
| Other income (expense) | 3,521 | (50,000) | 336,951 | (390,000) |
| Total other income (expense) | (343,605) | (137,691) | (541,922) | (450,619) |
| Net income (loss) | (724,643) | (376,720) | (1,329,681) | (2,292,589) |
| Net loss attributable to common stockholders | $ (724,643) | $ (376,720) | $ (1,329,681) | $ (2,292,589) |
| Weighted average shares outstanding – basic and diluted (in shares) | 681,000,979 | 466,219,492 | 571,229,584 | 348,089,518 |
| Weighted average loss per share – basic and diluted (in dollars per share) | $ (0) | $ (0) | $ (0) | $ (0.01) |